While B-type natriuretic peptide (BNP) levels remain high in patients with end-stage heart failure with cardiogenic shock, these levels lose their prognostic value in patients using ventricular assist ...

Brain natriuretic peptide (BNP), a substance secreted by the heart that is associated with congestive heart failure and renal failure, does not predict reduction in systolic blood pressure (BP) in ...

Analysts at BNP Paribas initiated Tesla shares with a bearish Underperform rating and $307 per share price target in a note to clients on Thursday, suggesting a potential 29% downside from current ...

B-type natriuretic peptide (BNP) as well as its N-terminal fragment (NT-proBNP) can provide useful diagnostic and prognostic information in patients with acute dyspnea and chronic heart failure.

Dr. Pankaj Arora, MD, FAHA, is a physician scientist in the Division of Cardiovascular Disease with expertise in the human genetics and genomics of complex cardiovascular traits, as well as ...

BNP Paribas SA's Q2 results were strong, but rising cost of risk and policy uncertainties may impact growth. Read why BNPQF ...

Diastolic heart failure is common in the elderly, particularly women. Previous studies on the value of brain natriuretic peptide in diastolic dysfunction have been largely limited to male subjects.

Luís Beck-da-Silva, MD; Adolfo de Bold, PhD, FRSC; Ross A. Davies, MD, FRCPC; Benjamin J.W. Chow, MD, FRCPC; Terrence D. Ruddy, MD, FRCPC; Margaret Fraser, RN ...

BNP Paribas SA continues to offer an attractive 6.8% forward dividend yield, supported by stable earnings and a sustainable ...